Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TBNK
12101
CALL
DELISTED
Territorial Bancorp Inc.
TBNK
| $38.6K | ﹤0.01% |
3,700
-600
| -14% | -$5.63K |
2024 Q2
1 quarter
|
|
12102
PUT
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.33B
| $38.6K | ﹤0.01% |
300
| – | – |
2022 Q4
7 quarters
|
|
12103
CALL
Distribution Solutions Group
DSGR
$1.62B
| $38.5K | ﹤0.01% |
+1,000
| New | +$34.1K |
2024 Q3
0 quarters
|
|
12104
CALL
Tempest Therapeutics
TPST
$13.3M
| $38.5K | ﹤0.01% |
2,115
-162
| -7% | -$3.32K |
2023 Q4
3 quarters
|
|
12105
PUT
Sutro Biopharma
STRO
$240M
| $38.4K | ﹤0.01% |
1,110
+740
| +200% | +$29K |
2022 Q4
7 quarters
|
|
12106
CALL
FingerMotion
FNGR
$16.8M
| $38.4K | ﹤0.01% |
+17,600
| New | +$36.4K |
2024 Q3
0 quarters
|
|
12107
PUT
Envela
ELA
$315M
| $38.4K | ﹤0.01% |
+7,000
| New | +$35.3K |
2024 Q3
0 quarters
|
|
12108
PUT
eHealth
EHTH
$24.3M
| $38.4K | ﹤0.01% |
9,400
+7,400
| +370% | +$32K |
2019 Q1
22 quarters
|
|
12109
CALL
Fathom Holdings
FTHM
$7.64M
| $38.3K | ﹤0.01% |
14,800
+14,600
| +7,300% | +$34.1K |
2022 Q4
7 quarters
|
|
12110
CALL
Kopin
KOPN
$907M
| $38.3K | ﹤0.01% |
52,400
+25,400
| +94% | +$23.3K |
2020 Q2
17 quarters
|
|
12111
PUT
Nicolet Bankshares
NIC
$3.43B
| $38.3K | ﹤0.01% |
400
-300
| -43% | -$28.1K |
2023 Q3
4 quarters
|
|
12112
CALL
SoundThinking
SSTI
$110M
| $38.2K | ﹤0.01% |
3,300
-1,700
| -34% | -$22.9K |
2023 Q3
4 quarters
|
|
|
CMU
12113
DELISTED
MFS High Yield Municipal Trust
CMU
| $38.2K | ﹤0.01% |
10,434
-10,684
| -51% | -$38K |
2024 Q1
2 quarters
|
|
12114
PUT
Spyre Therapeutics
SYRE
$7.06B
| $38.2K | ﹤0.01% |
1,300
-200
| -13% | -$5.57K |
2024 Q2
1 quarter
|
|
12115
PUT
Claros Mortgage Trust
CMTG
$171M
| $38.2K | ﹤0.01% |
5,100
+3,200
| +168% | +$26.6K |
2023 Q1
6 quarters
|
|
12116
CALL
Angi Inc
ANGI
$242M
| $38.2K | ﹤0.01% |
1,480
-410
| -22% | -$9.87K |
2018 Q3
24 quarters
|
|
12117
PUT
Bristow Group
VTOL
$1.19B
| $38.2K | ﹤0.01% |
1,100
+800
| +267% | +$28.9K |
2023 Q1
6 quarters
|
|
12118
CALL
Schwab Fundamental International Small Company Index ETF
FNDC
$3.1B
| $38.1K | ﹤0.01% |
+1,000
| New | +$36.2K |
2024 Q3
0 quarters
|
|
12119
PUT
Shinhan Financial Group
SHG
$36.6B
| $38.1K | ﹤0.01% |
900
+200
| +29% | +$8.19K |
2024 Q1
2 quarters
|
|
12120
PUT
Nomad Foods
NOMD
$1.53B
| $38.1K | ﹤0.01% |
2,000
-6,100
| -75% | -$112K |
2022 Q4
7 quarters
|
|
12121
CALL
Shenandoah Telecom
SHEN
$637M
| $38.1K | ﹤0.01% |
2,700
-300
| -10% | -$4.96K |
2024 Q2
1 quarter
|
|
12122
NuScale Power
SMR
$3.29B
| $38.1K | ﹤0.01% |
3,287
+3,284
| +109,467% | +$33.5K |
2024 Q1
2 quarters
|
|
|
ONL
12123
CALL
Orion Office REIT
ONL
$133M
| $38K | ﹤0.01% |
9,500
+3,700
| +64% | +$14.5K |
2021 Q4
11 quarters
|
|
12124
Mineralys Therapeutics
MLYS
$1.94B
| $38K | ﹤0.01% |
3,136
-9,898
| -76% | -$120K |
2023 Q3
4 quarters
|
|
12125
Research Solutions
RSSS
$68.9M
| $38K | ﹤0.01% |
13,901
-24,466
| -64% | -$65.9K |
2023 Q4
3 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.